/
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
Mentions
1 mention · latest on 5 Apr 2026
See which tracked investors hold Axsome Therapeutics, Inc. →Ownership and position changes on OwnershipTrace